World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000023519
Date of registration: 08/08/2016
Prospective Registration: No
Primary sponsor: Kanazawa Medical University
Public title: Objective olfaction test with olfacto-scintigraphy
Scientific title: Objective olfaction test with olfacto-scintigraphy - Objective olfaction test with olfacto-scintigraphy
Date of first enrolment: 2013/04/08
Target sample size: 120
Recruitment status: Recruiting
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027081
Study type:  Observational
Study design:  Not selected Not selected  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Hideaki Shiga
Address:  1-1 Daigaku, Uchinada-machi, Kahokugun, Ishikawa, JAPAN Japan
Telephone: 076-218-8147
Email: ent@kanazawa-med.ac.jp
Affiliation:  Kanazawa Medical University Otorhinolaryngology
Name:     Hideaki Shiga
Address:  1-1 Daigaku, Uchinada-machi, Kahokugun, Ishikawa, JAPAN Japan
Telephone: 076-218-8147
Email: ent@kanazawa-med.ac.jp
Affiliation:  Kanazawa Medical University Otorhinolaryngology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1) Patients who have serious visceral disease or have early history of the disease. 2) Patients who are pregnant, suspected to be pregnant or breastfeeding. 3) Patients who have early history of serious side-effects or allergy to thallium-201. 4) Patients who are considered not to be eligible by the investigator.

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
olfactory dysfunction
Intervention(s)
Primary Outcome(s)
Evaluation of olfactory nerve with Olfacto-scintigraphy 24 hrs after the nasal administration of thallium-201.
Secondary Outcome(s)
Secondary ID(s)
1387
Source(s) of Monetary Support
MEXT
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available: Yes
Date Posted:
Date Completed: 31/03/2021
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history